Efficacy and Safety of Topical Rosuvastatin and Melatonin vs. Placebo in Patients with Mild to Moderate Plaque Psoriasis: A Preliminary Randomized Double-Blinded Clinical Trial

    April 2024 in “ Skin research and technology ”
    Farhad Mohammadi, Fatemeh Zare Harofteh, Adeleh Sahebnasagh, Narges Ghaneei, Mohammad Ebrahimzadeh Ardakani, Fatemeh Saghafi
    Image of study
    TLDR Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.
    This randomized, double-blind clinical trial involving 77 patients with mild to moderate plaque psoriasis found that topical rosuvastatin and melatonin creams significantly reduced the severity of psoriasis compared to a placebo. Over 60 days, both treatments improved Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index (DLQI), and Disease Severity Score (DSS) without significant adverse effects. Melatonin cream showed a 51% reduction in PASI and a 61% reduction in DSS, while rosuvastatin cream showed a 70% reduction in PASI and a 73% reduction in DSS. These results suggest that both treatments are effective and safe, though larger trials are needed for confirmation.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    1 / 1 results

      community Fats on your Head to Stop Hair Loss?

      in Research/Science  142 upvotes 7 months ago
      The conversation discusses the potential of long-chain unsaturated fatty acids, like oleic and linoleic acid, as an additional treatment for hair loss, which may inhibit the enzyme responsible for converting testosterone to DHT and promote hair growth. Users humorously suggest using oils topically and discuss other hair loss treatments, but the main focus is on the science behind fatty acids and their role in hair health.